MedTrace Logo

Reduced Opioid Prescription After Laparoscopic Hysterectomy

NCT05548582 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-01-12

No results posted yet for this study

Summary

Given the nationwide epidemic of opioid use and abuse (in part due to over prescription), this study aims at addressing the need for opioid prescription after laparoscopic hysterectomy.

Conditions

  • Pain, Postoperative
  • Opioid Misuse
  • Opioid Use
  • Pain

Interventions

DRUG

OxyCODONE 5 mg Oral Tablet

No opioid prescription after laparoscopic hysterectomy

DRUG

Acetaminophen 500 mg Tab

Standard prescription

DRUG

Ibuprofen 600 mg

Standard prescription

Sponsors & Collaborators

Principal Investigators

  • Mostafa Borahay · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-12
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05548582 on ClinicalTrials.gov